Therapeutic Category
- Antineoplastic Agent, BCR-ABL Tyrosine Kinase Inhibitor
- Antineoplastic Agent, Tyrosine Kinase Inhibitor
Medication Safety Issues
Sound-alike/look-alike issues:
Nilotinib may be confused with bosutinib, cabozantinib, dasatinib, enasidenib, imatinib, neratinib, nilutamide, nintedanib, niraparib, PONATinib, regorafenib, SUNItinib, tepotinib, vandetanib
High alert medication:
This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.
